Free Trial

Solventum (SOLV) Competitors

Solventum logo
$77.90 -0.35 (-0.45%)
Closing price 07/3/2025 03:40 PM Eastern
Extended Trading
$77.90 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, IRTC, NARI, and BLCO

Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry.

Solventum vs. Its Competitors

GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

GE HealthCare Technologies has a net margin of 11.02% compared to Solventum's net margin of 4.55%. Solventum's return on equity of 31.01% beat GE HealthCare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies11.02% 24.95% 6.38%
Solventum 4.55%31.01%6.53%

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.1% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

GE HealthCare Technologies has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.

GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$19.67B1.77$1.99B$4.7516.03
Solventum$8.25B1.63$478M$2.1636.06

GE HealthCare Technologies currently has a consensus target price of $88.27, indicating a potential upside of 15.93%. Solventum has a consensus target price of $81.50, indicating a potential upside of 4.62%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Solventum
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18

In the previous week, GE HealthCare Technologies had 11 more articles in the media than Solventum. MarketBeat recorded 24 mentions for GE HealthCare Technologies and 13 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.38 beat Solventum's score of 1.19 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
18 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
7 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

GE HealthCare Technologies beats Solventum on 14 of the 17 factors compared between the two stocks.

Get Solventum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SOLV vs. The Competition

MetricSolventumMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$13.58B$7.31B$5.56B$20.73B
Dividend YieldN/A2.78%5.24%3.72%
P/E Ratio36.0627.9427.6528.06
Price / Sales1.6332.39419.5638.45
Price / Cash7.9020.3926.2118.22
Price / Book4.556.698.034.61
Net Income$478M$233.06M$3.18B$983.39M
7 Day Performance3.35%3.33%2.93%2.79%
1 Month Performance4.11%1.79%1.72%4.37%
1 Year Performance56.11%37.40%34.39%15.08%

Solventum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SOLV
Solventum
1.4521 of 5 stars
$77.90
-0.4%
$81.50
+4.6%
+56.1%$13.58B$8.25B36.0622,000News Coverage
Positive News
Analyst Upgrade
GEHC
GE HealthCare Technologies
4.1264 of 5 stars
$74.07
-0.4%
$88.27
+19.2%
-1.2%$33.92B$19.67B15.5950,000News Coverage
Positive News
Dividend Announcement
PHG
Koninklijke Philips
3.6779 of 5 stars
$23.99
-0.6%
N/A-9.7%$23.10B$19.50B55.7978,200
ZBH
Zimmer Biomet
4.8835 of 5 stars
$91.23
-0.3%
$111.53
+22.2%
-13.3%$18.05B$7.70B20.1817,000News Coverage
SNN
Smith & Nephew SNATS
3.0801 of 5 stars
$30.67
+1.5%
$28.00
-8.7%
+12.9%$13.43B$5.81B14.2017,349
PEN
Penumbra
4.7248 of 5 stars
$256.00
-0.2%
$302.40
+18.1%
+38.3%$9.91B$1.19B241.514,500Positive News
Insider Trade
STVN
Stevanato Group
1.5312 of 5 stars
€24.51
-0.5%
N/A+32.7%€7.42B€1.19B48.065,521News Coverage
Positive News
Gap Down
GKOS
Glaukos
4.5563 of 5 stars
$103.42
+2.0%
$134.67
+30.2%
-14.9%$5.91B$383.48M-43.64780Positive News
IRTC
iRhythm Technologies
1.1591 of 5 stars
$153.96
-0.5%
$138.60
-10.0%
+43.1%$4.92B$618.59M-49.032,000Insider Trade
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
BLCO
Bausch + Lomb
3.0868 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-6.0%$4.61B$4.79B-12.6513,500High Trading Volume

Related Companies and Tools


This page (NYSE:SOLV) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners